Number of Shares
2.85 Mil
Current Holdings Value*
$112.25 Mil
% of Portfolio
8.08%
Total Estimate Gain
$65.05 Mil
% of Total Estimate Gain
64.30%

Soleus Capital Management, L.P.'s TG Therapeutics Inc Holding Summary

As of 2025-03-31, Soleus Capital Management, L.P. held 2.85 Mil shares of TG Therapeutics Inc(TGTX), totaling $112.25 Mil. This investment constitutes 8.08% of their stock portfolio, and Soleus Capital Management, L.P. now holds 1.79% of the outstanding TG Therapeutics Inc(TGTX) stock.

The initial trade took place in 2022Q4. And since then Soleus Capital Management, L.P. has made 7 purchases of TGTX, at an average price of $15.55, for a total of 6.51 Mil shares. In addition, there have been 3 sales at an average price of $15.93 for 3.66 Mil shares. Based on historical transaction data and TGTX's current price of $37.91, Soleus Capital Management, L.P.'s estimated gain on his TGTX holdings is $65.05 Mil, reflecting a 64.30% gain to date.

Soleus Capital Management, L.P. TGTX ($37.91) Holding Chart

Soleus Capital Management, L.P. TGTX ($37.91) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1